Selective Pharmacological Targeting of a DEAD Box RNA Helicase

• Lisa Lindqvist,

  Affiliation Department of Biochemistry, McGill University, Montreal, Quebec, Canada

  ⨯
• Monika Oberer,

  Affiliation Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Mikhail Reibarkh,

  Affiliation Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Regina Cencic,

  Affiliation Department of Biochemistry, McGill University, Montreal, Quebec, Canada

  ⨯
• Marie-Eve Bordeleau,

  Affiliation Department of Biochemistry, McGill University, Montreal, Quebec, Canada

  ⨯
• Emily Vogt,

  Affiliation Department of Biology, McGill University, Montreal, Quebec, Canada

  ⨯
• Assen Marintchev,

  Affiliation Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Junichi Tanaka,

  Affiliation Department of Chemistry, Biology, and Marine Sciences, University of the Ryukyus, Nishihara, Okinawa, Japan

  ⨯
• Francois Fagotto,

  Affiliation Department of Biology, McGill University, Montreal, Quebec, Canada

  ⨯
• Michael Altmann,

  Affiliation Institut für Biochemie und Molekulare Medizin, Universität Bern, Bern, Switzerland

  ⨯
• Gerhard Wagner,

  Affiliation Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Jerry Pelletier

  *E-mail: jerry.pelletier@mcgill.ca

  Affiliations Department of Biochemistry, McGill University, Montreal, Quebec, Canada, McGill Cancer Center, McGill University, Montreal, Quebec, Canada

  ⨯